In Canada a specimen can be refused for a clinical reason or for a packaging reason, and the packaging reason is the one overseas-trained staff often miss. PHO guidance expects diagnostic specimens moving to a laboratory to comply with the federal Transportation of Dangerous Goods packaging rules, to arrive without leakage, and to carry complete, non-conflicting labelling. Missing or contradictory markings are grounds for rejection on their own, even when the specimen inside is perfectly acceptable. In the US, acceptance is governed by CDC and CLIA-style laboratory requirements plus the carrier's own packaging instructions.
The practical consequence is simple: two identical specimens drawn the same morning can meet different fates depending on how the box was built and marked, not on how good the sample was.
What are the standard specimen rejection criteria?
Most laboratories publish an acceptance list, and the same handful of clinical criteria appear on both sides of the border:
- Identification failure. No patient identifier, only one identifier where two are required, or a name that does not match the requisition.
- Leakage or contamination. A wet primary container, blood on the outside of the tube, or a soiled request form.
- Wrong container or additive. A tube with the wrong anticoagulant, a non-sterile container where a sterile one is required, or an expired container.
- Volume or quality problems. Insufficient volume for the ordered tests, a clotted specimen where clotting invalidates the method, or gross haemolysis where the assay cannot tolerate it.
- Transport failure. A delay beyond the stated stability window, or a temperature excursion outside the range the test requires.
- Labelling conflict. A label that disagrees with the requisition, an overwritten label, or two labels naming different patients.
When a laboratory rejects on one of these points, the rejection is documented and the ordering clinic is usually asked to recollect. That is why the most effective fix in a clinic is not a bigger fridge or a faster courier — it is a packaging routine that removes the rejection reasons that have nothing to do with the patient.
What does TDG packaging add to Canadian rejection criteria?
Canada layers a transport regulation on top of the clinical list. Ontario's TDG packaging rules, which follow the federal Transportation of Dangerous Goods framework, treat a diagnostic specimen as a dangerous good that must be packed and marked according to the category it belongs to. In everyday clinic language that means the specimen is prepared in the layered structure the rules expect: a leakproof primary container, absorbent material capable of taking the full volume if the primary fails, a secondary container that itself resists leakage, and a rigid outer package with the correct markings for the category.
Where a Canadian laboratory or courier applies that layer, a shipment can be refused for reasons a clinical checklist never mentions: no absorbent in the secondary layer, an outer package whose marking does not describe the contents, a marking that conflicts with the waybill, or a bag that cannot hold pressure without leaking. PHO's acceptance expectations put leakage and certain labelling failures in the rejection list for exactly this reason — the packaging is part of the specimen's integrity, not an administrative wrapper around it.
How do the Canadian and US acceptance lists compare?
| Item | Canada | United States |
|---|---|---|
| Governing acceptance framework | PHO guidance for specimen acceptance, plus the federal TDG packaging rules referenced by Ontario's transport requirements | CDC and CLIA-style laboratory requirements, plus the carrier's packaging instruction |
| Packaging layer in the rejection decision | Explicit. Packaging that does not meet the TDG requirements, or that leaks, can be rejected on its own | Driven mainly by the carrier's published packaging instruction and the shipper's own SOP |
| Marking failures treated as rejection triggers | Yes — missing markings or markings that conflict with the contents are rejection reasons | Yes at carrier level, with the shipper usually bearing responsibility for compliance |
| Leakage standard | Primary container must not leak in transport; absorbent must take the total volume | Same practical standard, tested through carrier acceptance programmes |
| Typical ambient specimen handling | Layered packaging with a marked outer container for transport to the receiving lab | Layered packaging per the carrier instruction, with comparable absorbent expectations |
| Where the clinic still owns the risk | Building and marking the package before it leaves the room | Same — acceptance starts with the person who sealed the bag |
How should a clinic package a specimen so it is not rejected?
Build every specimen the same way, in layers, at the point of collection rather than at the door:
- Close the primary container tightly and wipe the outside. If the outside is wet, change the container.
- Place the primary into a transport bag or secondary container with enough absorbent for the full volume.
- Seal the secondary layer, then place it into a rigid outer package or a carrier-approved tote.
- Attach the paperwork to the outside in a way that keeps it dry, and make sure the patient details on the bag and on the requisition agree.
- Mark the package for the category of specimen inside, and check that the marking matches what you typed on the waybill.
Two supply choices carry most of this load. A 95 kPa specimen bag gives you a secondary layer that holds pressure without leaking, and a 3-wall specimen transport bag adds a built-in absorbent layer for smaller tubes. Both are stocked alongside the rest of the clinic collection lines, so the packaging step uses one consistent bag across the site.
Which rejections point to a supply problem rather than a staff problem?
Sort your rejection log by cause before you retrain anyone. If the same cause keeps appearing — bags that are too small for the tube rack, no absorbent in the drawer, a marking label that smears when the bag is sealed — the fix is a supply change, not another reminder. Rejections caused by identification and labelling conflict are usually training and workflow issues: two people handling the same specimen, or a requisition printed after the bag was sealed. Run the log monthly, split it into clinical causes, packaging causes and workflow causes, and act on the largest bucket. A clinic that stops guessing and starts categorising usually removes most of its packaging rejections within a month, because packaging failures repeat in exactly the same shape.
For a worked walkthrough of the same method applied to one specific rejection pattern, see Cutting specimen rejections: a worked example.
Related reading
- Cutting specimen rejections: a worked example
- Specimen receipt and processing SOP: chain of custody and traceability
- 95 kPa specimen bags vs 3-wall transport bags
Ordering for a clinic, lab or care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers.
Frequently Asked Questions
Can a lab reject a specimen because of its packaging alone?
Yes. In Canada, packaging that does not meet the federal TDG packaging rules for the specimen category — a leaking primary container, a missing absorbent, or an outer package with missing or contradictory markings — can be rejected even when the specimen itself is fine.
What is the difference between a rejected specimen and a cancelled test?
A rejection is a decision made against the specimen when it arrives, usually for identification, leakage, container, volume or transport reasons. A cancelled test is a decision made about the order itself, for example because the test was duplicated or the ordering information was incomplete.
Do Canadian and US labs use the same rejection list?
The clinical criteria overlap closely, since both countries reject unlabelled, leaking, clotted, low-volume or delayed specimens. The Canadian list carries an extra transport layer, because the federal TDG packaging rules make correct layered packing and correct markings part of acceptance.
What should be inside the secondary packaging of a specimen shipment?
The sealed primary container plus enough absorbent material to take the entire specimen volume if the primary container fails. The secondary layer must resist leakage on its own, and the whole assembly then goes into a rigid outer package that carries the required markings.
CliniEco Medical is a licensed medical device establishment (MDEL #35334).
0 commentaire